How lowering the price of a common asthma drug made it harder to get

Wall Street Journal

29 December 2023 - To avoid Medicaid penalties, Glaxo and other drug makers lowered prices. 

For popular asthma drug Flovent HFA, the tactic to replace it with a generic backfired.

Read Wall Street Journal article

Michael Wonder

Posted by:

Michael Wonder